Pickup In Korea Biopharma IPO Activity Signals Improving Investor Sentiment

 
• By Jung Won Shin

Following strong demand for offerings by D&D Pharmatech and ENCell, sentiment around biopharma IPOs in Korea appears to be improving, with several other ventures planning to float.

market recovery
South Korea's D&D Pharmatech, ENCell See Strong IPO Demand (Shutterstock)

More from Focus On Asia

More from Business